Efficacy and safety of lenalidomide for the treatment of acute myeloid leukemia: a systematic review and meta-analysis

BACKGROUND: Lenalidomide is effective for the treatment of low-risk myelodysplastic syndromes with deletion 5q abnormalities. However, whether lenalidomide leads to a significant improvement in treatment response and overall survival (OS) in cases of acute myeloid leukemia (AML) remains controversia...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Chun-Hong, Wei, Min, Yang, Fei-Yan, Wu, Fu-Zhen, Chen, Lei, Wang, Jian-Kun, Liu, Qin, Huang, Jin-Xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152603/
https://www.ncbi.nlm.nih.gov/pubmed/30271212
http://dx.doi.org/10.2147/CMAR.S168610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152603/
https://www.ncbi.nlm.nih.gov/pubmed/30271212
http://dx.doi.org/10.2147/CMAR.S168610

Ejemplares similares